INVITAE CORP's ticker is NVTA and the CUSIP is 46185L103. A total of 290 filers reported holding INVITAE CORP in Q2 2022. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,567 | -46.4% | 4,241 | 0.0% | 0.00% | – |
Q2 2023 | $4,792 | -30.6% | 4,241 | -17.1% | 0.00% | – |
Q1 2023 | $6,905 | -29.3% | 5,115 | -2.6% | 0.00% | – |
Q4 2022 | $9,772 | -24.8% | 5,254 | +3.1% | 0.00% | – |
Q3 2022 | $13,000 | +30.0% | 5,094 | +20.0% | 0.00% | – |
Q2 2022 | $10,000 | -71.4% | 4,244 | -4.7% | 0.00% | -100.0% |
Q1 2022 | $35,000 | -47.0% | 4,452 | +3.8% | 0.00% | -50.0% |
Q4 2021 | $66,000 | -36.5% | 4,291 | +16.9% | 0.00% | -50.0% |
Q3 2021 | $104,000 | -14.0% | 3,670 | +2.5% | 0.00% | -20.0% |
Q2 2021 | $121,000 | +4.3% | 3,582 | +18.3% | 0.01% | 0.0% |
Q1 2021 | $116,000 | -1.7% | 3,029 | +7.0% | 0.01% | -16.7% |
Q4 2020 | $118,000 | -4.1% | 2,832 | 0.0% | 0.01% | -14.3% |
Q3 2020 | $123,000 | +83.6% | 2,832 | +29.0% | 0.01% | +75.0% |
Q2 2020 | $67,000 | +131.0% | 2,196 | +2.6% | 0.00% | +33.3% |
Q1 2020 | $29,000 | -9.4% | 2,140 | +7.0% | 0.00% | +50.0% |
Q4 2019 | $32,000 | -17.9% | 2,000 | 0.0% | 0.00% | -33.3% |
Q3 2019 | $39,000 | -17.0% | 2,000 | 0.0% | 0.00% | -25.0% |
Q2 2019 | $47,000 | 0.0% | 2,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $47,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EMORY UNIVERSITY | 104,861 | $1,560,000 | 2.11% |
Baker Brothers Advisors | 6,554,967 | $97,538,000 | 0.86% |
SECTORAL ASSET MANAGEMENT INC | 929,765 | $13,835,000 | 0.58% |
Camber Capital Management LP | 500,000 | $7,440,000 | 0.51% |
Rock Springs Capital Management LP | 400,000 | $5,952,000 | 0.43% |
Redmile Group, LLC | 181,224 | $2,563,000 | 0.21% |
Perceptive Advisors | 299,583 | $2,306,000 | 0.14% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 166,666 | $2,480,000 | 0.08% |
CORRADO ADVISORS, LLC | 11,860 | $176,000 | 0.08% |
Orbimed Advisors | 456,666 | $6,795,000 | 0.05% |